noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

TD SYNNEX Corporation

Technology Committee Charter (Technology Committee Charter FNL 061825)
TD SYNNEX Corporation

Nominating and Corporate Governance Committee Charter (NCG Committee[...]
TD SYNNEX Corporation

Compensation Committee Charter (Compensation Committee Charter FNL 092424)

Healthcare

Genentech Inc.

10/19/2025 | Press release | Distributed by Public on 10/19/2025 23:04

FDA Approves Genentech’s Gazyva for the Treatment of Lupus Nephritis

Read this content

Click here to read the original version at the source's official website. The text of this article is not available at the moment.

Genentech Inc. published this content on October 19, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 20, 2025 at 05:04 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]

Back